|
Market Closed -
NYSE
21:00:02 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 221.15 USD | +0.02% |
|
-0.33% | -8.19% |
Company Valuation: ResMed, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30,691 | 32,133 | 28,117 | 37,762 | 28,145 | 31,638 | - | - |
| Change | - | 4.7% | -12.5% | 34.31% | -25.47% | 12.41% | - | - |
| Enterprise Value (EV) 1 | 31,192 | 33,346 | 28,585 | 37,221 | 27,335 | 30,685 | 30,028 | 29,323 |
| Change | - | 6.9% | -14.28% | 30.21% | -26.56% | 12.25% | -2.14% | -2.35% |
| P/E | 39.6x | 35.9x | 27.7x | 27.1x | 18.7x | 19x | 17.3x | 15.7x |
| PBR | 9.35x | 7.76x | 5.78x | 6.33x | 4.27x | 4.57x | 4.11x | 4.21x |
| PEG | - | 2.4x | 2x | 0.7x | 1.93x | 1.6x | 1.77x | 1.6x |
| Capitalization / Revenue | 8.58x | 7.61x | 6x | 7.34x | 4.98x | 5.45x | 5.13x | 4.79x |
| EV / Revenue | 8.72x | 7.9x | 6.1x | 7.23x | 4.84x | 5.29x | 4.87x | 4.44x |
| EV / EBITDA | 26.8x | 25.3x | 18.1x | 19.8x | 11.7x | 13.6x | 12.4x | 11.4x |
| EV / EBIT | 31.2x | 27.2x | 19.3x | 21.1x | 13.4x | 14.7x | 13.3x | 12.1x |
| EV / FCF | 144x | 58.1x | 22x | 22.4x | 16.6x | 18.7x | 16.9x | 15.4x |
| FCF Yield | 0.69% | 1.72% | 4.55% | 4.46% | 6.03% | 5.36% | 5.93% | 6.48% |
| Dividend per Share 2 | 1.68 | 1.8 | 1.92 | 2.12 | 2.46 | 2.66 | 2.931 | 3.207 |
| Rate of return | 0.8% | 0.82% | 1% | 0.82% | 1.26% | 1.2% | 1.33% | 1.45% |
| EPS 2 | 5.3 | 6.09 | 6.92 | 9.51 | 10.43 | 11.63 | 12.77 | 14.05 |
| Distribution rate | 31.7% | 29.6% | 27.7% | 22.3% | 23.6% | 22.9% | 23% | 22.8% |
| Net sales 1 | 3,578 | 4,223 | 4,685 | 5,146 | 5,653 | 5,806 | 6,171 | 6,600 |
| EBITDA 1 | 1,162 | 1,317 | 1,576 | 1,884 | 2,329 | 2,249 | 2,417 | 2,577 |
| EBIT 1 | 1,000 | 1,224 | 1,478 | 1,763 | 2,039 | 2,088 | 2,259 | 2,419 |
| Net income 1 | 779.4 | 897.6 | 1,021 | 1,401 | 1,523 | 1,641 | 1,781 | 1,915 |
| Net Debt 1 | 501.5 | 1,213 | 468.9 | -541.2 | -809.9 | -953.6 | -1,610 | -2,315 |
| Reference price 2 | 209.63 | 218.50 | 191.42 | 258.00 | 194.88 | 221.15 | 221.15 | 221.15 |
| Nbr of stocks (in thousands) | 146,405 | 147,062 | 146,884 | 146,365 | 144,421 | 143,062 | - | - |
| Announcement Date | 11/08/22 | 03/08/23 | 01/08/24 | 31/07/25 | 06/08/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.01x | 5.28x | 13.63x | 1.2% | 31.64B | |
| 33.55x | 5.86x | 22.46x | 0.27% | 241B | |
| 37.53x | 6.7x | 21.23x | 0.64% | 149B | |
| 44.07x | 11.66x | 25.74x | -.--% | 142B | |
| 16.51x | 3.39x | 11.05x | -.--% | 62.65B | |
| 34.11x | 6.82x | 21.58x | -.--% | 49.1B | |
| 33.56x | 6.64x | 22.54x | 0.6% | 46.99B | |
| 18.65x | 2.28x | 11.55x | 2.7% | 47.13B | |
| 43.7x | 10.61x | 23.39x | -.--% | 45.65B | |
| 76.92x | 7.32x | 22.3x | -.--% | 41.81B | |
| Average | 35.76x | 6.66x | 19.55x | 0.54% | 85.68B | |
| Weighted average by Cap. | 36.07x | 6.99x | 21.02x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RMD Stock
- Valuation ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions
